Targeted Oncology11 小时
Defibrotide Does Not to Prevent Sinusoidal Obstruction Syndrome in High-Risk Pediatric HSCT
Defibrotide prophylaxis after HSCT did not reduce sinusoidal obstructive syndrome incidence in high-risk pediatric patients, per retrospective study at 2025 Tandem Meeting.